Pharma Major Lupin Limited reported its financial performance for the first quarter ending June 30th, 2017, missed estimates Key Financial & Performance Highlights Net Sales for the quarter were Rs. 3806.80 crore compared to Rs. 4116.90 crore in Q4 FY2017 and Rs. 4341.80 crore in Q1 FY2017; Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) for the quarter was Rs. 800.30 crore compared to Rs. 826.70 crore in Q4 FY2017 and Rs. 1393.40 crore in Q1 FY2017; Net profits for the quarter were Rs. 358.10 crore compared to Rs. 380.20 crore in Q4 FY2017 and Rs. 882.00 crore in Q1 FY2017;Investment in...